News from NYU Langone Health
A Blood Test To Screen For Colon Cancer May Be On The Horizon. (NBC News)
NBC News (3/13) “‘We’ve been anticipating and waiting excitedly for a blood-based test for colon cancer,’ said Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine and Gastroenterology, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health, saying the test has been “a long time coming.”
This Risk Assessment Tool Helped Olivia Munn Discover Her Breast Cancer. (CNN)
CNN (3/13) “Having access to a breast cancer risk assessment tool empowers patients, Ruth Oratz, MD, clinical professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, said in an email Wednesday.”
Maternal Deaths Overestimated With Reliance On Pregnancy Checkbox. (Washington Post)
The Washington Post (3/13) “However the data is calculated, the pattern remains the same, said Colleen Denny, MD, clinical associate professor, Department of Obstetrics and Gynecology, NYU Langone Hospital—Brooklyn as well as a fellow of the American College of Obstetricians and Gynecologists,” who was not involved with the study.
HealthDay (3/13) “Lower, stable maternal mortality rates are seen on identification of maternal deaths by requiring mention of pregnancy among multiple causes of death, according to a study published online March 12 in the American Journal of Obstetrics & Gynecology,” with study coauthor Justin S. Brandt, MD, associate professor, director, Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, saying in a statement, “By not relying on the pregnancy checkbox, our approach avoided the misclassification that has given the false impression of increasing maternal mortality rates in the United States.”
Why Online Shopping Is Tanking Your Mental Health. (TIME)
TIME (3/13) “‘The act of filling the cart or purchasing the item can almost feel more powerful than actually getting it,’ says Thea Gallagher, PsyD, clinical assistant professor, Department of Psychiatry.”
Brittany Mahomes Sparks Discussion Over A Common, But Taboo Postpartum Issue. (Parents Magazine)
Parents Magazine (3/13) “‘Historically, not a lot of attention has been paid to” postpartum pelvic floor issues, “so many women may brush them off, thinking they are ‘normal’ or something they just have to live with,’ says Lauren E. Stewart, MD, assistant professor, Departments of Obstetrics and Gynecology, and Urology.
Aaron Judge May Not Be Ready For Yankees Opening Day After Swing Discomfort. (New York Post)
The New York Post (3/12) Aaron Judge “did go through some defensive drills on a backfield in Tampa on Tuesday, which was a positive sign, according to Harshil Matta, DO, clinical assistant professor, Department of Orthopedic Surgery.
Using Gen AI To Translate Medical Jargon In Discharge Notes. (Patient Engagement HIT)
Paywall* PatientEngagementHIT “Using too much medical jargon in discharge notes may not be conducive to patient engagement, but researchers from NYU Langone Health are exploring how generative AI can fix that problem.”
NCAA Chief Medical Officer Brian Hainline Announces Retirement. (AP)
The AP (3/13) “NCAA chief medical officer and senior vice president Brian W. Hainline, MD, clinical professor, Department of Neurology, and Indiana University’s School of Medicine,” is now “retiring after more than a decade in the position.”
First-Line Niraparib Maintenance Is Not Associated With Worse HRQOL In Advanced Ovarian Cancer. (OncLive)
OncLive (3/13) “Although frontline maintenance therapy with niraparib (Zejula) was associated with an early, transient increase in gastrointestinal (GI) symptoms, patients treated with the PARP inhibitor did not experience a worsening of overall health-related quality of life (HRQOL) compared with those given placebo, according to patient-reported outcomes (PROs) from the phase 3 PRIMA trial,” with lead study author, Bhavana Pothuri, MD, professor, Department of Obstetrics and Gynecology and Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, and colleagues writing, “Placebo LS mean change from baseline scores [for fatigue] remained consistent through cycle 18 and showed no difference compared with niraparib.”
Atlantic Health, NYU Langone Partner On Heart Care. (Becker's Hospital Review)
Becker’s Hospital Review (3/13) “Morristown, N.J.-based Atlantic Health System’s Morristown Medical Center and New York City-based NYU Langone Health expanded their partnership to include adult congenital heart disease services,” which “will provide patients with more convenient access to specialized cardiovascular care and provide expertise from both organizations.” In a release, Dan G. Halpern, MD, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, program director of NYU Langone Heart’s Adult Congenital Heart Disease (ACHD) Program, said, “Our partnership with experts at Morristown Medical Center will provide advanced adult congenital heart disease care to patients in New Jersey, allowing them to stay in their local community.”
Sometimes Kids Need A Push. Here’s How To Do It Kindly. (Vox)
Vox (3/13) “It’s common for caregivers to attend parent-teacher conferences and be shocked by how much their kids are capable of, says Judith F. Joseph, MD, clinical assistant professor, Department of Child and Adolescent Psychiatry.”
Insights Into Living Kidney Donor Health, Racial Disparities. (Pulmonology Advisor)
Pulmonology Advisor (3/13) “According to Mara A. McAdams-DeMarco, PhD, associate professor, Departments of Surgery and Population Health, Center for Surgical and Transplant Applied Research, and colleagues, ‘Segregation at the residential and transplant center neighborhoods may be a key mechanism driving racial inequalities; to address racial disparities in [living kidney transplantation] access, it is crucial to identify interventions that can be targeted at the community and healthcare levels.’”
Prilenia Eyes 2025 Launch For Huntington’s Drug Pridopidine. (Pharmaphorum (UK))
Pharmaphorum (UK) (3/13) “Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine in the EU, despite mixed results in a phase 3 trial;” a “subgroup analysis was prespecified in the trial protocol, recognising the difficulty of enrolling HD patients who were not already taking medication, according to PROOF-HD’s lead North American investigator Andrew S. Feigin, MD, professor, associate chair for NYU Network and Clinical Research, Department of Neurology.”
NYU Langone Health Physician Discusses FDA Approval Of Wegovy For Cardiovascular Issues. (KARE-TV Minneapolis)
KARE-TV (3/13) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, discussed the recent FDA approval of Wegovy for reducing the risk of heart attacks and strokes.
Long COVID Could Be The Cause Of Your Bad Hangovers, Study Finds: ‘Bad Reaction’. (Fox News)
Fox News (3/11) “A small study by Stanford University...examined alcohol sensitivity in four people with long COVID,” and Fox News medical contributor Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine, “who was not involved in the study, noted that although this research surveyed only four patients, he also has recognized an increased sensitivity to alcohol in some of his own PASC patients.”
